Impact of donor high-risk social behaviors on recipient survival in cardiac transplantation

Transplantation

Volumn 89, Issue 7, 2010, Pages 873-878

  Xu, David S ^a,b   Hartman, Deanna ^b   Ludrosky, Kristin ^b   Campbell, James ^b   Starling, Randall C ^b   Taylor, David O ^b   Smedira, Nicholas G ^b   Gonzalez Stawinski, Gonzalo V ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac transplant; High risk donor; Survival; Viral transmission

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; NARCOTIC AGENT;

ADULT; ARTICLE; BODY PIERCING; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; KAPLAN MEIER METHOD; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL BEHAVIOR; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TATTOOING; VIRUS TRANSMISSION;

ADULT; BODY PIERCING; CRIME; DONOR SELECTION; FEMALE; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PRISONERS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TATTOOING; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77950952556     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ca56e0     Document Type: Article

References (26)

1. Copeland JG. Only optimal donors should be accepted for heart transplantation: Protagonist. J Heart Lung Transplant 1995; 14(6pt 1): 1038.
2. Jeevanandam V, Furukawa S, Prendergast TW, et al. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996; 62: 1268.
3. Laks H, Marelli D. The alternate recipient list for heart transplantation: A model for expansion of the donor pool. Adv Card Surg 1999; 11: 233.
4. Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: Lessons learned from 25 years of experience. Transpl Int 2008; 21: 113.
5. Sung RS, Galloway J, Tuttle-Newhall JE, et al. Organ donation and utilization in the United States, 1997-2006. Am J Transpl 2008; 8(4 pt 2): 922.
6. Gasink LB, Blumberg EA, Localio AR, et al. Hepatitis C virus seropos-itivity in organ donors and survival in heart transplant recipients. JAMA 2006; 296: 1843.
7. Shea KJ, Sopko NA, Ludrosky K, et al. The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation. Eur J Cardiothorac Surg 2007; 31: 452; discussion 456.
8. Potapov EV, Loebe M, Hubler M, et al. Medium-term results of heart transplantation using donors over 63 years of age. Transplantation 1999; 68: 1834.
9. Drinkwater DC, Laks H,BlitzA,et al. Outcomesof patients undergoing transplantation with older donor hearts. J Heart Lung Transplant 1996; 15: 684.
10. Bennett LE, Edwards EB, Hosenpud JD. Transplantation with older donor hearts for presumed "stable" recipients: An analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998; 17: 901.
11. Houyel L, Petit J, Nottin R, et al. Adult heart transplantation: Adverse role of chronic alcoholism in donors on early graft function. J Heart Lung Transplant 1992; 11: 1184.
12. Freimark D, Aleksic I, Trento A, et al. Hearts from donors with chronic alcohol use: A possible risk factor for death after heart transplantation. J Heart Lung Transplant 1996; 15: 150.
13. Grauhan O, PatzurekJ, HummelM, et al. Donor-transmitted coronary atherosclerosis. J Heart Lung Transplant 2003; 22: 568.
14. Marelli D, Laks H, Bresson S, et al. Results after transplantation using donor hearts with preexisting coronary artery disease. J Thorac Cardio-vasc Surg 2003; 126: 821.
15. Grauhan O, Siniawski H, Dandel M, et al. Coronary atherosclerosis of the donor heart\Impact on early graft failure. Eur J Cardiothorac Surg 2007; 32: 634.
16. Pondrom S. News and issues that affect organ and tissue transplantation. Am J Transplant 2009; 9: 247.
17. Leikin JB, Heyn-Lamb R, Aks S, et al. The toxic patient as a potential organ donor. Am J Emerg Med 1994; 12: 151.
18. Hantson P, Vekemans MC, Squifflet JP, et al. Outcome following organ removal from poisoned donors: Experience with 12 cases and a review of the literature. Transpl Int 1995; 8: 185.
19. Houser SL, MacGillivrayT, Aretz HT. The impact ofcocaineonthe donor heart: A case report. J Heart Lung Transplantat 2000; 19: 609.
20. Freimark D, Czer LS, Admon D, et al. Donors with a history of cocaine use: Effect on survival and rejection frequency after heart transplantation. J Heart Lung Transplant 1994; 13: 1138.
21. Grady D. Four transplant recipients contract H.I.V. New York Times, November 13, 2007.
22. Steenhuysen J. Transplant patients should know risks. International Herald Tribune. New York, NY, Stephen Dunbar-Johnson 2008.
23. Halpern SD, Shaked A, Hasz RD, et al. Informing Candidates for solid-organ transplantation about donor risk factors.N EnglJMed 2008; 358: 2832.
24. Haji SA, Starling RC, Avery RK, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004; 23: 277.
25. Haji SA, Avery RK, Yamani MH, et al. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant 2006; 25: 294.
26. el Oakley RM, Yonan NA, Simpson BM, et al. Extended criteria for cardiac allograft donors: A consensus study. J Heart Lung Transplant 1996; 15: 255.